Orbimed Advisors LLC Relay Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$8.24 - $12.97 $4.14 Million - $6.51 Million
501,966 New
501,966 $4.22 Million
Q3 2021

Nov 15, 2021
SELL
$29.75 - $37.99 $10.4 Million - $13.3 Million
-350,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$32.81 - $45.1 $11.5 Million - $15.8 Million
350,000 New
350,000 $14.9 Million

Others Institutions Holding RLAY

# of Institutions
203
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $535M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email